Quantification of Biliverdin, Bilirubin and Bilirubin Glucuronide in Micro-Samples of Animal Blood.
- 1Department of Life Sciences, University of Trieste, Via Giorgieri 1, 34127 Trieste, Italy.
- 2Department of Agricultural, Food, Environmental and Animal Sciences, University of Udine, Via Sondrio, 2/A, 33100 Udine, Italy.
Abstract
Circulating bile pigments are routinely measured in human and veterinary medicine, toxicology, pharmacology, and biomedical studies, as they are consolidated biomarkers of liver dysfunction and hemolysis and emerging biomarkers of biological responses to stress. This study was performed to extend bile pigment analysis from plasma to microvolumes of whole blood not only to simplify the pre-analytical steps but also to surmount the bottleneck of limited blood volume available for withdrawals in screening and monitoring. We applied the HUG assay for the nanoscale analysis of biliverdin, bilirubin, and bilirubin glucuronide. HUG is a chimeric protein expressing the UnaG domain that emits fluorescence upon binding bilirubin. This study shows that, under specific conditions, the HUG assay enables quantification of the three bile pigments in rat and fish whole blood. Moreover, quantification is equivalent in blood, plasma and serum. This approach skips pre-analytical steps, reduces errors and time to analysis, thereby facilitating research of circulating bile pigments in animalia while preserving the possibility of comparing new data with historical sets of clinical chemistry data in the literature.
Related
- Molecular Fingerprinting Enables Mass Quantification and Semi-Quantitative Source Apportionment of Black Carbon in Biological Samples and Beyond
- Hours Since Last Drink Is Associated With Multiple Urine Ethyl Glucuronide Cutoffs Among Individuals With Alcohol Use Disorder
- Timing luteal urinary pregnanediol glucuronide assessment using urinary luteinizing hormone: agreement with ultrasound-determined ovulation
- Urinary 27-nor-5β-cholestane-3α,7α,12α,24R,25S-pentol glucuronide as a biomarker of non-small cell lung cancer in never-smokers: two independent case-control studies
- Association between chest pain and serum total bilirubin levels in adults : Cross-sectional analysis of NHANES 2005 to 2018
BibTeX
@article{sist2026quantification,
title = {{Quantification of Biliverdin, Bilirubin and Bilirubin Glucuronide in Micro-Samples of Animal Blood.}},
author = {Paola Sist and Federica Tramer and Marco Stebel and Donatella Volpatti and Sabina Passamonti},
journal = {Biosensors},
year = {2026},
month = sep,
doi = {10.3390/bios16100529},
url = {https://europepmc.org/article/MED/42930076},
note = {CC BY},
}
RIS
TY - JOUR
TI - Quantification of Biliverdin, Bilirubin and Bilirubin Glucuronide in Micro-Samples of Animal Blood.
AU - Paola Sist
AU - Federica Tramer
AU - Marco Stebel
AU - Donatella Volpatti
AU - Sabina Passamonti
PY - 2026
DA - 2026/09/22
JO - Biosensors
DO - 10.3390/bios16100529
UR - https://europepmc.org/article/MED/42930076
AB - Circulating bile pigments are routinely measured in human and veterinary medicine, toxicology, pharmacology, and biomedical studies, as they are consolidated biomarkers of liver dysfunction and hemolysis and emerging biomarkers of biological responses to stress. This study was performed to extend bile pigment analysis from plasma to microvolumes of whole blood not only to simplify the pre-analytical steps but also to surmount the bottleneck of limited blood volume available for withdrawals in screening and monitoring. We applied the HUG assay for the nanoscale analysis of biliverdin, bilirubin, and bilirubin glucuronide. HUG is a chimeric protein expressing the UnaG domain that emits fluorescence upon binding bilirubin. This study shows that, under specific conditions, the HUG assay enables quantification of the three bile pigments in rat and fish whole blood. Moreover, quantification is equivalent in blood, plasma and serum. This approach skips pre-analytical steps, reduces errors and time to analysis, thereby facilitating research of circulating bile pigments in animalia while preserving the possibility of comparing new data with historical sets of clinical chemistry data in the literature.
SN - 2079-6374
ER -